Premium
Selegiline hydrochloride and cognition
Author(s) -
Lees A. J.
Publication year - 1991
Publication title -
acta neurologica scandinavica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.967
H-Index - 95
eISSN - 1600-0404
pISSN - 0001-6314
DOI - 10.1111/j.1600-0404.1991.tb05027.x
Subject(s) - selegiline , euphoriant , anxiety , depression (economics) , iproniazid , parkinson's disease , psychomotor learning , psychomotor retardation , dementia , psychology , hydrochloride , cognition , medicine , disease , psychiatry , monoamine oxidase , chemistry , biochemistry , alternative medicine , organic chemistry , pathology , economics , macroeconomics , enzyme
Selegiline HCl, 10 mg per day has been reported to improve attention and episodic memory in Parkinson's disease and early Alzheimer's disease. Selegiline also improves motor reaction times in Parkinson's and subjective feelings of increased vitality, euphoria and energy. At doses of between 10 and 40 mg a day it has also been shown to improve, depression particularly when psychomotor retardation is prominent and anxiety minimal.